Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From William Masters
C-Suite Snippets: Behind The Scenes At Gates Medical Research Institute
In case you missed it: catch up with snippets from interviews recently published by In Vivo.
'Serial Killer’ CAR-T Could Help Autolus Bounce Back
Data presentations at next week’s ASH meeting will be vital for Autolus to restore confidence in pipeline.
Accessing CAR-T Therapies
Infographic: There are two CAR-T therapies on the market, both of which secured their first approvals in 2017. The pipeline of autologous and allogeneic CAR-T options is busy with several candidates in clinical studies. However, getting approval is only one part of getting these breakthrough therapies to patients.
European Biotechs Enter the IPO Big League
2019 has seen European biotech companies making waves in the US IPO space. Genmab’s listing was a blockbuster, but many more companies have proven their ability to go public on the NASDAQ.
C-Suite Snippets: Open Data And Innovation
In case you missed it: catch up with snippets from interviews published by In Vivo this month.
C-Suite Snippets: Targeting Metastasis In Cancer Therapy
In case you missed it: catch up with snippets from interviews published by In Vivo this month.